Skip to content
Clinical Trials – home

Olanzapine: A Comprehensive Guide for Patients

3 / 7
trials open to patients / all trials
10+
Countries

In short

Olanzapine, also known by the brand name Zyprexa, is an antipsychotic medication that has been the subject of numerous clinical trials. These studies aim to evaluate its effectiveness and safety in treating various mental health conditions, as well as its potential applications in other areas of medicine. This article summarizes key findings from clinical trials investigating olanzapine's use in schizophrenia, bipolar disorder, autism, and chemotherapy-induced nausea and vomiting.

At a glance

Conditions Studied
Schizophrenia, Bipolar Disorder, Autism, Chemotherapy-Induced Nausea and Vomiting
Dosage Forms
Oral tablets, Orally disintegrating wafers, Intramuscular injections, Nasal spray (experimental)
Dose Ranges
2.5 mg to 20 mg daily, with variations based on condition and study design
Primary Outcome Measures
PANSS, CGI-S, YMRS, Quality of Life scales, Safety assessments
Study Durations
Short-term (few weeks) to long-term (up to 104 weeks)
Notable Side Effects
Weight gain, Increased blood glucose, Elevated prolactin levels, Sedation
Comparators
Placebo, Other antipsychotics (e.g., haloperidol), Standard treatments
Special Populations
Children with autism, Cancer patients, Healthy volunteers (for bioequivalence studies)

What is Olanzapine?

Olanzapine is a medication that belongs to a class of drugs called atypical antipsychotics. It is widely known by its brand name Zyprexa. This medication is used to treat various mental health conditions and has been the subject of numerous clinical trials to evaluate its effectiveness and safety.

Conditions Treated with Olanzapine

Olanzapine is primarily used to treat the following conditions:

  • Schizophrenia: A severe mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behavior.
  • Bipolar Disorder: A mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression).
  • Acute Agitation: A state of extreme restlessness and emotional distress often associated with psychiatric conditions.

Additionally, research is ongoing to explore the use of olanzapine in other conditions:

  • Autism: A developmental disorder that affects communication and behavior.
  • Chemotherapy-Induced Nausea and Vomiting: Olanzapine is being studied as a potential treatment to prevent nausea and vomiting in cancer patients undergoing chemotherapy.

How Olanzapine Works

Olanzapine works by affecting certain chemicals in the brain, primarily dopamine and serotonin. These chemicals, also known as neurotransmitters, play crucial roles in regulating mood, behavior, and thought processes. By modulating the activity of these neurotransmitters, olanzapine helps to alleviate symptoms associated with various mental health conditions.

Dosage Forms and Administration

Olanzapine is available in several forms:

  • Oral tablets: These are the most common form, typically taken once or twice daily.
  • Orally disintegrating tablets (Zydis): These tablets dissolve quickly in the mouth and are useful for patients who have difficulty swallowing.
  • Intramuscular injection (IM): Used for rapid treatment of acute agitation.
  • Long-acting injection (Olanzapine Pamoate Depot): Administered every 2-4 weeks for long-term treatment.

The dosage of olanzapine varies depending on the condition being treated and the individual patient's response. It's crucial to take olanzapine exactly as prescribed by your healthcare provider.

Effectiveness of Olanzapine

Clinical trials have shown that olanzapine can be effective in treating various mental health conditions:

  • In schizophrenia, olanzapine has been shown to improve symptoms such as hallucinations, delusions, and disorganized thinking.
  • For bipolar disorder, olanzapine can help manage manic episodes and may be used in combination with other medications for maintenance treatment.
  • In acute agitation, rapid-acting forms of olanzapine can help calm patients quickly.

The effectiveness of olanzapine can vary from person to person, and it may take several weeks to see the full benefits of the medication.

Side Effects and Safety Considerations

Like all medications, olanzapine can cause side effects. Some common side effects include:

  • Weight gain and increased appetite
  • Drowsiness or sedation
  • Dizziness
  • Dry mouth
  • Constipation

More serious side effects, though less common, can include:

  • Increased blood sugar levels, which may lead to or worsen diabetes
  • High cholesterol levels
  • Changes in heart rhythm
  • Increased risk of stroke in elderly patients with dementia-related psychosis

It's important to discuss any side effects with your healthcare provider. Regular monitoring of weight, blood sugar, and cholesterol levels is typically recommended for patients taking olanzapine.

Ongoing Research and Future Applications

Researchers continue to study olanzapine to better understand its effects and explore new potential uses:

  • Studies are investigating the use of olanzapine in combination with other medications for enhanced effectiveness in treating mental health conditions.
  • Research is ongoing to determine the optimal dosage of olanzapine for preventing chemotherapy-induced nausea and vomiting in cancer patients.
  • Long-term studies are being conducted to assess the safety and effectiveness of olanzapine in children with autism.

As research progresses, our understanding of olanzapine and its potential applications continues to grow, potentially leading to improved treatments for various conditions in the future.

Questions people often ask

Conditions where Olanzapine is being studied

Each condition opens its own overview and trial list

Trials with Olanzapine

Recruiting trials first

See all 7 →
Quick filters
  • Participants:All ages
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).